Accelerant Holdings (ARX): Results of Operations and Financial Condition
Accelerant Holdings (ARX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d286225dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Accelerant Announces Second Quarter 2026 Results Accelerant Cancels Earnings Conference Call Following Announcement of Agreement with Thoma Bravo to Become a Private Company Second Quarter 2026 Results • Exchange Written Pr
How this was made
The 30-second read
Why it matters
Traders get fresh quarterly performance data plus a major corporate event that changes the information set (no guidance) and shifts focus toward deal progression, terms, and timing.
Market read
This is a combined earnings-and-deal disclosure: Q2 shows strong growth and profitability, while the take-private agreement removes near-term guidance and increases deal-driven trading focus.
What to watch
The company explicitly updates non-GAAP definitions (excluding investment gains/losses) and provides no Q3/full-year guidance, which can change how traders model forward earnings and deal economics.
Background
Accelerant filed an 8-K with Q2 2026 results and referenced a separate definitive agreement to be acquired by Thoma Bravo, leading to cancellation of the scheduled earnings call.
Ticker impact
Accelerant reports Q2 2026 results and discloses it has a definitive agreement with Thoma Bravo to become private, canceling the earnings call and guidance.
Near-term trading likely bifurcates between upbeat operating metrics and deal-arbitrage dynamics, with guidance uncertainty adding volatility.
The filing includes specific Q2 financial metrics (exchange written premium, net income, adjusted EBITDA) and a definitive agreement to be acquired, plus explicit cancellation of the call and no Q3/full-year guidance due to the pending transaction.
Market effects
Highlights continued growth in specialty insurance exchange models and the role of private-equity-backed platform consolidation.
Primarily US-listed small-cap risk exchange sentiment; limited direct regional spillover.
Thoma Bravo deal framing may influence cross-border specialty insurance tech M&A expectations, but no additional global specifics are provided.
Counterpoint
Strong Q2 exchange metrics may be less predictive for equity value if the take-private terms imply a discount or if deal timing/conditions introduce execution risk.
Key entities
- public_companyAccelerant Holdings
NYSE-listed risk exchange platform reporting Q2 2026 results and disclosing a definitive take-private agreement with Thoma Bravo.
- private_equityThoma Bravo
Acquirer in a definitive agreement to take Accelerant private, prompting cancellation of the earnings call and removal of guidance.
